Tezacitabine is an investigational synthetic nucleoside analogue classified as a fluorinated cytidine derivative designed to inhibit DNA synthesis in rapidly dividing cells. As an antineoplastic agent,… Read more
Tezacitabine is an investigational synthetic nucleoside analogue classified as a fluorinated cytidine derivative designed to inhibit DNA synthesis in rapidly dividing cells. As an antineoplastic agent, this compound acts by interfering with ribonucleotide reductase function and is primarily studied for its potential in treating various solid tumors and leukemia. This category provides access to high-quality reference standards of the active pharmaceutical ingredient, alongside related impurities, metabolites, and stable isotope-labelled compounds. These materials are essential tools for pharmaceutical laboratories engaged in rigorous analytical testing, impurity profiling, and method validation. By utilizing these precise standards, researchers can ensure the accuracy of their quantitative assays and the integrity of quality control processes throughout the drug development lifecycle.